Luca Bertero

78PUBLICATIONS
322CO-AUTHORS
Molecular targetsPredictive and prognostic markersRegenerative medicine (incl. stem cells)Epidemiological modellingMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (78)

|Nov 04, 2026
Ex vivo therapy-driven selection of glioblastoma stem-like cells models resistance evolution.

|Sep 30, 2026
Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition.

|Sep 21, 2026
Simpson Grading and Risk of Recurrence in 4074 Meningioma Patients With Gross Total Resection.

|Sep 05, 2026
Prognostic Markers in Meningioma: Effectiveness of FISH-Assessed CDKN2A/B Homozygous Deletion and Limits of Surrogate p16/MTAP Immunohistochemistry in Predicting Disease-Specific Survival.

|Aug 28, 2026
Variation in meningioma recurrence risk estimates across observational cohorts: the influence of calendar time, WHO classifications, geographical settings, and healthcare systems.

|Aug 19, 2026
Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapy.

Pageof 13

Frequent Collaborators

20 joint publications

Paola Cassoni

11 joint publications

Alessia Pellerino

11 joint publications

Fulvio Borella

9 joint publications

Stefano Cosma